Promoter holding
64.27%
GA
Ghv Advanced Care Private Limited - Due diligence report
A 360° intelligence report on Pristyn Care: trust score, financial health, credit view, compliance, directors, growth and distress signals -…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Pristyn Care — 360° Intelligence Report
Generated from MCA filings & public records66/100
Trust Score
Moderate
Pristyn Care is assessed as Moderate with a Trust Score of 66/100. Pristyn Care is an active private limited indian non-government company incorporated in 2018, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.
Report generated on 07 Aug 2026 from the latest processed filings. Ghv Advanced Care Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
66/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
50/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
70/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 3 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 60/100 Moderate
- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 38%).
- Working-capital cover adequate.
Charges position: 0 open (-) · 4 satisfied (212.42 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 4 | 48.0 cr |
Compliance Score: 50/100 Moderate
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 3 court forum(s).
- 1 auditor resignation(s) filed - latest: SANGAL & ASSOCIATES on 2019-08-05.
- Delayed payments to MSME suppliers disclosed (99 disclosure(s)).
- 20 active GST registration(s).
Legal cases on record (3)
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| HARSIMARBIR SINGH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VAIBHAV KAPOOR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GARIMA SAWHNEY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- HARSIMARBIR SINGH has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
2
Group entities
2
Capital events
16 allotment(s) · 10 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Ghv Technologies Private Limited | Subsidiary Company | 74.00% |
| Ghv Medical Anchor Private Limited | Subsidiary Company | 74.00% |
| Lybrate Inc. | Subsidiary Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 2 year(s).
Latest year revenue grew 2.1x.
Operating for 7 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 24% in a year.
Compliance score is weak (50/100).
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 1.34 cr.
3 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence64/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment60/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view73/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events03 Dec 2025
Charge satisfied
Hdfc Bank Limited
08 Jan 2025
Charge satisfied
Hdfc Bank Limited
26 Dec 2024
Last AGM held
Annual general meeting
25 Oct 2024
Charge created
Hdfc Bank Limited - 100.00 cr
31 Mar 2024
Latest balance sheet
Filed with ROC
01 Jul 2023
Charge satisfied
Hdfc Bank Limited
31 Mar 2023
Share transfer (FY 2023)
75.00000000 shares to Tenacity Ventures Fund I
16 Mar 2023
Charge created
Hdfc Bank Limited - 79.00 cr
02 Jan 2023
Charge created
Hdfc Bank Limited - 30.00 cr
01 Jun 2022
Securities allotted
15240 Debentures - 15.30 cr raised
31 Mar 2022
Share transfer (FY 2022)
194.00000000 shares to Internet Fund VII Pte. Ltd
Share transfer (FY 2022)
194.00000000 shares to Internet Fund VII Pte. Ltd.
Share transfer (FY 2022)
109.00000000 shares to Internet Fund VII Pte. Ltd.
28 Jan 2022
Securities allotted
149 Preference Shares - 74.78 cr raised
22 Dec 2021
Securities allotted
85 Equity Shares - 4.27 cr raised
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 2 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
3 active director(s) / partner(s); review board churn before relying on management continuity.
20 active GST registration(s) indicate ongoing business operations.
All 4 registered charge(s) stand satisfied - past borrowings repaid.
Operates a group structure with 2 subsidiary(ies) - assess on a consolidated basis.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 16 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Hufort Healthcare Private Limited | U24230MH2004PTC147961 | Mumbai, Maharashtra, India |
| Jai Ambey Emergency Services (I) Private Limited | U63030CT2015PTC001776 | Raipur, Chattisgarh, India |
| Tata Industries | U44003MH1945PLC004403 | Mumbai, Maharashtra, India |
| Lifecell | U85196TN2004PTC053577 | Chennai, Tamil Nadu, India |
| Ayushman Medical Diagnostics Pvt Ltd | U85195MP1990PTC006089 | Bhopal, Madhya Pradesh, India |
| Vhealth | U85100DL2008PTC184571 | New Delhi, Delhi, India |
| Akumentis | U72900DL2010PLC206414 | Delhi, Delhi, India |
| Srl Diagnostics | U74899PB1995PLC045956 | Mohali, Punjab, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Pristyn Care before audits and certifications: compliance score 50/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Pristyn Care: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Pristyn Care - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 66/100, distress signals and MSME payment-delay disclosures - know whether Pristyn Care pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Pristyn Care - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Pristyn Care an active company?
Pristyn Care has MCA status “Active” with a compliance score of 50/100 (Moderate).
Is Pristyn Care financially healthy?
Pristyn Care has a Financial Health Score of 70/100 (Moderate) based on its filed financial statements.
Should I do business with Pristyn Care?
Its overall Trust Score is 66/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Pristyn Care?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Pristyn Care have loans or charges against its assets?
No open charges - all 4 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Pristyn Care up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 50/100 (Moderate).
Is it risky to lend to Pristyn Care?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
